XX4-17168-34300 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-08-22
Dose 1 — Pfizer-BioNTech
2021-10-09
Dose 2 — Pfizer-BioNTech
2021-10-22
Registered in v-safe
2021-10-22
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-10-23
Health check-in — day 14, dose 2
Feeling: Fair

Adult check-in
2021-10-30
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-11-06
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-11-13
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-11-20
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2022-01-08
Survey response — 3 months, dose 2
MedDRA: Cough, Headache, Muscular weakness, Respiratory tract congestion, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Tested positive for COVID 12/25. muscle weakness, congestion, headache and cough

MedDRA releases: 2024-11 · check-in free text available
2022-01-08
Report sent to call center — 3 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-01-10
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-08-22	Pfizer-BioNTech	No
2	2021-10-09	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-01-08	Successful 2022-01-10	Participant prefers to complete VAERS report online

Free text

Release 10 — 3 months, dose 2

2022-01-08

Symptoms: Tested positive for COVID 12/25. muscle weakness, congestion, headache and cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Headache	·	·	✓
SD	Muscular weakness	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	SARS-CoV-2 test positive	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release